Metformin use lowers risk of neurodegenerative diseases in diabetes patients - Video

Published On 2022-03-19T16:15:07+05:30 | Updated On 19 March 2022 4:15 PM IST

Overview

A recent meta-analysis showed that metformin use, especially long-term use is tied to a lower risk of neurodegenerative disease (ND) in diabetes patients. However, the researchers add, "owing to a substantial heterogeneity among studies, there is a need for high-quality randomized controlled trials to confirm the finding."

There has always been a controversy on the association between metformin use and neurodegenerative disease onset. To clarify the same, Zubing Mei, Anorectal Disease Institute of Shuguang Hospital, Shanghai, China, and colleagues aimed to determine the relationship between metformin use and ND risk based on data from population-based cohort studies in a systematic review and meta-analysis published in the journal Diabetic Medicine.

For more information check out the full story on the link below:

Metformin use lowers risk of neurodegenerative diseases in diabetes patients

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751